Newsroom

Sorted by: Latest

-

NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics expanded its partnership with Indica Labs to scale AI-powered digital pathology and support more timely, consistent diagnostic insights....
-

Permian Resources Announces Third Quarter 2026 Earnings Conference Call

MIDLAND, Texas--(BUSINESS WIRE)--Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) announced today that it will report third quarter 2026 financial and operating results after the market closes for trading on Wednesday, November 4, 2026. Management will host an earnings conference call on Thursday, November 5, 2026 at 9:00 a.m. Central (10:00 a.m. Eastern). Interested parties are invited to participate on the call by dialing (833) 461-5787 (Conference ID: 727909291...
-

Diality Hosts "Expanding Choice in Hemodialysis" Expert Panel Discussion at ASN Kidney Week 2026

IRVINE, Calif.--(BUSINESS WIRE)--Diality Inc., a medical device company responsible for the development of the Moda-flx™ Hemodialysis System, has announced a panel discussion entitled “Expanding Choice in Hemodialysis” to be held on Friday, October 23 during the American Society of Nephrology’s Kidney Week 2026 in Denver. Expert panelists will discuss clinical evidence pertaining to hemodiafiltration (HDF) and perspectives for successful integration into kidney care in the United States. “We ar...
-

Forge First Asset Management lance des séries FNB et des séries couvertes en dollars américains pour ses stratégies alternatives

TORONTO--(BUSINESS WIRE)--Forge First Asset Management Inc. (« Forge First »), filiale en propriété exclusive de Gestion mondiale d’actifs CI (« GMA CI »), annonce le lancement de séries FNB et de séries couvertes en $ US de ses fonds alternatifs liquides, offrant ainsi aux investisseurs un accès accru à ces stratégies axées sur la recherche d’un équilibre entre la préservation du capital et la croissance à long terme. Le placement initial des parts des séries FNB des fonds est maintenant termi...
-

Forge First Asset Management Launches ETF Series and USD Hedged Series of its Alternative Strategies

TORONTO--(BUSINESS WIRE)--Forge First Asset Management launches ETF and U.S. dollar hedged series of its two liquid alternative funds. The ETF series trade today on the TSX....
-

Redwire Secures Additional Orders to Deliver Stalker UAS to U.S. National Guard for the Army’s Next-Generation Drone Operators

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced it will deliver Redwire’s Stalker Uncrewed Aircraft Systems (UAS) in support of the National Guard Bureau’s evolving mission requirements and UAS modernization priorities. The value of the purchase orders was approximately $13.8 million. The long range, Group 2 Stalker UAS will provide National Guard instructors with a highly reliable, modular platform...
-

Canada Goose to Announce Second Quarter Fiscal Year 2027 Financial Results on November 5, 2026

TORONTO--(BUSINESS WIRE)--Canada Goose Holdings Inc. (NYSE, TSX: GOOS) plans to announce results for the second quarter of fiscal year 2027, which ended September 27, 2026, before markets open on Thursday, November 5, 2026. The Company will host a conference call and webcast to discuss second quarter fiscal 2027 results at 8:30am ET on Thursday, November 5, 2026. A live webcast of the conference call will be available on the company’s website at http://investor.canadagoose.com. The conference c...
-

Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, focused on inherited cardiovascular disorders, today announced that the company will attend Chardan’s 10th Annual Healthcare Conference. The company will participate in a panel on Tuesday, October 20, 2026, at 11:30 AM ET and host investor meetings. About Rocket Pharmaceuticals, Inc. Rocket Pha...
-

LifeMine Therapeutics Forms Clinical Advisory Board of Leading Experts in Organ Transplantation

WATERTOWN, Mass.--(BUSINESS WIRE)--LifeMine Therapeutics Inc., a clinical-stage biopharmaceutical company pioneering Top-Down Drug Discovery™, which leverages digital genomic search technology from fungi to source next-generation precision medicines, today announced the formation of its clinical advisory board, bringing together leading physicians and researchers with deep expertise across organ transplantation, transplant immunology and immunosuppression. Members will help advise LifeMine on th...
-

Marsh Reports Third Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--Marsh (NYSE: MRSH), a global leader in risk, reinsurance and capital, people and investments, and management consulting, today reported financial results for the third quarter ended September 30, 2026. John Doyle, President and CEO, said: "Marsh delivered a strong third quarter, generating 5% underlying revenue growth and double-digit EPS growth. We also made significant progress in executing our Thrive program and successfully completed our brand transition." "These...